ISSN (print): 2073-4034, ISSN (online): 2414-9128 Founder: LLC “Bionika Media” Editor-in-Chief: Sychev D.A., Corresponding Member of RAS, Doctor of Sc., Full Professor Frequency / Assess: 14 issues per year / Subscription Included in: Higher Attestation Commission List, RISC
ICMJE (International Committee of Medical Journal editors) recommends authorship to be based on the following 4 criteria: Significant contribution to the study concept and design, or the acquisition and analysis of data, or their interpretation Writing the first version of the article or substantial revision of its important intellectual content Final approval of the publication version 4. Consent to be responsible for all aspects of the work and ensure appropriate consideration and resolution of issues related to the accuracy and integrity of all parts of the work. In addition to responsibility for the part of the work that was done by the author, the author should be able to indicate co-author who is responsible for the other parts of the work. Furthermore, authors should be assured of the good faith contribution of their co-authors. All persons designated as authors must meet all four criteria for authorship, and all persons who meet the criteria for authorship must be listed in the list of authors. Persons who do not meet all four criteria for authorship should be listed in the “Acknowledgements” section. These criteria for authorship are designed to ensure that the status of authorship is given to those who are trustworthy and can take responsibility for the published work. These criteria should not serve as a means of excluding colleagues who meet the remaining criteria, by depriving them of the ability to meet criteria 2 or 3. Therefore, all persons meeting the first criterion should be able to participate in the processing, writing of the first version of the manuscript and its final approval for publication. The persons conducting the work are responsible for identifying those who meet these criteria and, ideally, should do it during the planning of the work, and, as the work proceeds, make the necessary changes. Authors, but not the magazine in which the work is submitted, should jointly establish that all persons listed in the list of authors meet all four criteria. The magazine editors’ tasks do not include determining who meets or does not meet the requirements for authorship, or the resolution of conflicts related to authorship. If it is not possible to reach an agreement on who can be qualified as an author, the study site(s), but not the magazine editor, should be asked for resolution of the disputed issue. If authors are asked to remove or add an author after submitting or publishing a manuscript, magazine editors should receive appropriate explanations and a signed statement of consent from all the authors listed for the requested change, as well as from the author whose name should be removed or added. The corresponding author is primarily responsible for communicating with the magazine in the process of submitting, reviewing and publishing the manuscript, and he usually ensures that all administrative requirements of the magazine are met correctly, for example, specifying the authors' details, obtaining approval from the ethics committee and clinical registration documents, and collecting forms and conflict of interest statements. However, these responsibilities may also be assigned to one or more of the other co-authors. The corresponding author must be available throughout the process of submitting and reviewing the manuscript in order to promptly answer editorial questions, as well as after publication, to respond to criticism of the work and provide any data and additional information upon editorial request if there are any questions about the article after its publication. Although the corresponding author is primarily responsible for correspondence with the magazine, ICMJE recommends editors to send copies of all correspondence to all the authors listed. If the study is conducted by a large group, ideally, this group should decide who will be the author before starting work and confirm this decision before submitting the manuscript to the magazine. All members of the group included in the list of authors must meet all four criteria for authorship, including the approval of the final version of the manuscript, accept public responsibility for this work and have complete confidence in the accuracy and integrity of the work of the other members of the group of authors. They must also personally complete the conflict of interest forms. Some large groups of authors denote authorship by the name of the group, with or without indication of individuals. When submitting a manuscript on behalf of a group of authors, the corresponding author must indicate the name of the group, if any, and clearly identify the members of the group who can be entrusted with the reliance and responsibility for this work as authors. If the byline of article indicates who is directly responsible for the manuscript, and MEDLINE will list all authors indicted in byline. If the byline contains the group name, MEDLINE will list the individual members of the group who are authors, as well as participants, who are sometimes called as non-authors contributors, if available the note to the byline that clearly indicates that the list of individual participants is given in article elsewhere, and which of these participants is the author or another contributor. Other participants of the work who do not meet all 4 criteria of authorship mentioned above should not be indicated as authors, but they should be thanked. Examples of activities that alone (without any other contribution to the work) cannot be considered a sufficient basis for authorship include fundraising, general management of a research group or general administrative support, writing assistance, technical editing, linguistic editing, and proofreading. Individuals whose contribution does not qualify as authorship can be thanked individually or collectively as a group under one heading (for example, “Clinical Researchers” or “Research Participants”), and their specific contribution should be indicated (for example, “participated as a scientific consultant ","critically evaluated the study plan", "collected data", "included patients in the study and participated in their treatment", "participated in the writing or technical editing of the manuscript"). Since the inclusion in the “Acknowledgements” section may imply confirmation of the data and the conclusion of the study by persons who will be thanked, editors are encouraged to ask the corresponding author to obtain written permission to be mentioned in “Acknowledgements” from all persons who will be thanked.
Immunopathogenesis of itching in Hodgkin’s lymphoma: current status
Itching is a frequent and debilitating symptom of Hodgkin’s lymphoma (HL), significantly reducing the quality of life of patients. This review is devoted to current understanding of the mechanisms of itching in this disease to deepen our understanding of the pathogenesis of this symptom and search for new therapeutic strategies aimed at improving the quality of life of patients. The role of various factors, including cytokines, histamine and neurotransmitters, in its development is analyzed. Particular attention is paid to the interaction of these mechanisms and their impact on the intensity and duration of itching. Promising research areas that contribute to a deeper understanding of the pathogenesis of this symptom and the development of new therapeutic strategies are also analyzed. The need for an interdisciplinary approach to early diagnostics of Hodgkin’s lymphoma, taking into account itching as one of the possible clinical manifestations, and the importance of timely treatment are emphasized.
Clinical and pathogenetic patterns of rosacea development
Rosacea (RC) is a chronic facial dermatosis that affects 2 to 10% of the population and is more common in women after the third decade of life. RC has a significant burden on patients, as it has significant consequences for physical and mental health. Both neurovascular and immunological factors play an important role in the pathogenesis. Recurrent clinical symptoms of RC affect appearance, are irritating and negatively affect emotional health. Significant correlations are known between RC and neuropsychiatric diseases that can affect cognitive functions, including depression, dementia, anxiety disorders, and migraine. With a long course of the disease, purulent-septic complications, deterioration of vision, distortion of facial features, and formation of scars on the skin may appear. Modern methods of treating RC with neurogenic changes are limited and reduce satisfaction, patient confidence in therapy, and can also aggravate psychological stress. Early seeking of help and proper treatment will help reduce inflammation and stop the development of the disease. The article describes the pathogenetic features of the development of RC, reveals neurovascular changes and autonomic dysregulation. The relationship between RC and various concomitant mental disorders is described in detail, clinical features and types of the disease are considered. Clinical manifestations of neurogenic RC and its distinctive features in comparison with other subtypes of this dermatosis are given.
Anogenital psoriasis: literature review and clinical case
Psoriasis is one of the most common dermatological diseases in the world. With a global prevalence of 2–5%, psoriasis can affect all age groups of the population. At the same time, the disease has a significant negative impact on the quality of life of patients, especially when the skin is affected in the anogenital area. The prevalence of isolated anogenital psoriasis (AGP) is estimated at 2 to 5% of all patients with psoriasis. However, generalized plaque or intertriginous psoriasis also affects the genital skin in 29–40% of cases. In addition, the prevalence of AGP is probably underestimated due to the reluctance of both patients and health care providers to discuss anogenital localization and quality of life. As a rule, AGP is associated with significant general and sexual quality of life impairments, higher rates of depression. Sexual dysfunction, decreased frequency of sexual activity and avoidance of intimate relationships are the result of not only objective symptoms (e.g., cracks or pain during/after sexual activity) but also psychosocial effects (embarrassment, fear of stigmatization). It should be noted that AGP symptoms affect the patient’s daily life, social, psychological and work aspects of life. The authors dwell in detail on the features of clinical manifestations of AGP, illustrating them with examples from their own practice. Particular attention in the review is paid to methods of topical and systemic treatment of AGP (including genetically engineered biological drugs). The authors conclude that AGP is often left without due attention, and timely prescription of therapy leads to a significant improvement in the quality of life of patients
Modern strategy for managing patients with follicular occlusion syndrome
Follicular occlusion syndrome is a chronic inflammatory skin disease that includes hidradenitis suppurativa, acne conglobata, abscessed disruptive folliculitis, Hoffman’s perifolliculitis, epithelial coccygeal passage. The disease has a chronic, continuously relapsing course and has a serious impact on the patient’s quality of life. Early diagnosis and treatment can effectively slow down the progression of the disease, prevent the formation of disfiguring scars, reduce the pathological impact of the disease on the somatic and mental health of patients, and reduce the economic burden. Currently, there is no consensus on the treatment of follicular occlusion syndrome. The article highlights and discusses existing approaches to the treatment of this complex category of patients in the world.
Skin melanoma: an analytical literature review and clinical cases
Melanoma, a malignant melanocytic tumor, remains one of the most aggressive forms of malignant skin tumors and is a significant public health problem. Despite progress in early diagnosis and treatment, melanoma continues to be the leading cause of death from skin cancer. The development of skin melanoma (SM) is a multistage process involving a complex relationship between genetic mutations, signaling pathways, and the tumor microenvironment. The main risk factors for SM remain unchanged, including ultraviolet radiation, genetic predisposition, phenotype, immunosuppression, and patient age. Advances in molecular biology have identified key signaling pathways involved in the development of SM. Mutations in the BRAF, NRAS, KIT, and NF1 genes are the most common. Melanoma is characterized by a complex interaction with the immune system. The cellular immune response, which involves cytotoxic T lymphocytes (CTLs), is important for tumor control, but melanoma is able to suppress this response. SM is a complex and heterogeneous disease. In recent years, significant progress has been made in understanding the molecular mechanisms and developing new treatments. However, further research to improve treatment outcomes and prevent this disease is required. Early diagnosis is critical for a favorable prognosis. The authors present clinical cases of melanocytic skin cancer from personal practice.
Generalized pustular psoriasis. literature review and clinical experience with IL-17 inhibitor therapy
The article presents current literature data on the clinical manifestations and course of generalized pustular psoriasis (GPP), which is one of the most severe forms of psoriasis. The publication briefly presents the main features of the immunopathogenesis of GPP, the role of proinflammatory interleukin IL-17 in the development of the psoriatic process, and also highlights approaches to treating the disease. Clinical cases of GPP therapy using monoclonal antibodies that inhibit proinflammatory IL-17A, which are the active ingredient of secukinumab, are presented. A pronounced clinical effect of treatment is shown. The described clinical cases indicate that the genetically engineered biological drug secukinumab can be the drug of choice in the treatment of patients with GPP when other treatment methods are ineffective, and its use is effective and safe.
Physiotherapeutic approach in the treatment of rosacea. Modern approaches to the treatment of rosacea through the prism of pathogenesis
Rosacea is a chronic dermatological disorder characterized by recurrent inflammatory episodes and vascular alterations. One of the promising therapeutic approaches for this condition is light-based therapy, particularly the use of intense pulsed light (IPL) technology. This method has demonstrated significant efficacy in reducing the severity of vascular and inflammatory manifestations, while maintaining a favorable safety profile. Despite the well-established clinical effectiveness of IPL therapy in managing rosacea, optimization of treatment parameters remains an ongoing challenge. This article presents current evidence on the efficacy of IPL therapy for rosacea treatment, explores the pathogenesis and key procedural parameters of this method, and shares our experience with advanced technological solutions in this field.
Bite pathology in patients with signs of undifferentiated connective tissue dysplasia (UCTD). Possibilities of aesthetic correction of changes in the lower third of the face in patients with UCTD after orthodontic treatment
Background: The possibilities of modern medicine allow to improve the appearance of a person’s face without resorting to radical surgical interventions. One of the frequent requests in the practice of a cosmetologist is the elimination of aesthetic problems that patients experience after completing orthodontic correction of the dentoalveolar system. As a rule, this changes the volume of soft tissues of the lower third of the face, hypertonicity of the masticatory muscles occurs, nasolabial folds increase, patients note skeletonization of the face, a change in the oval – a feeling of an “aging” face appears. And, of course, these changes cause psychological discomfort to the patient. Objective: Determination of the incidence of bite pathology in patients with signs of undifferentiated connective tissue dysplasia (UCTD) and the presence of polymorphisms of the genes responsible for the synthesis of collagen and elastin. Materials and methods: The pilot study involved 71 patients. All patients underwent genetic testing, questionnaires on the presence of phenotypic features of UCTD, assessment of the risk of UCTD and bite pathology. Results: The results of the study show that the study groups have significant differences in the presence of bite pathology, which is confirmed by low p values for most of the analyzed markers. Particularly pronounced differences were observed for the genetic markers rs7787362_ELN and risk, which may indicate their importance in predicting bite pathology. Significant differences were also found for the marker rs1800012_COL1A1, which may indicate its role in this pathology. Patients without bite pathology have significantly higher chances of having the rs1800012_COL1A1_CC and rs7787362_ELN_TT genotypes. Patients with bite pathology more often have rs7787362_ELN_CC genotypes, a high risk according to the questionnaire. These data highlight the importance of genetic testing for assessing the risk of developing bite pathology and may help in developing individualized approaches to treatment and prevention. Patients with bite pathology malocclusion (group 1) have significantly higher scores on the questionnaire (15.0 [13.0; 16.0]) compared to patients without pathology (group 0, 10.0 [8.0; 10.0]). This indicates that the presence of bite pathology was associated with higher values in the questionnaire, which may reflect more pronounced clinical or demographic features in this group. The conducted correlation analysis showed that there was a significant correlation between bite pathology and undifferentiated connective tissue dysplasia (R=0.619; p<0.001*). Also, the presence of polymorphism in the rs7787362_ELN gene significantly increases the risk of bite pathology, while the rs1800012_COL1A1 and rs7787362_ELN genes with no polymorphisms have a protective value in predicting the absence of bite pathology. Conclusion: Modern achievements in aesthetic medicine make it possible to effectively correct changes that occur during or as a result of orthodontic correction, which can cause psychological discomfort in the patient. Interdisciplinary interaction between orthodontists and cosmetologists will play a special role in the future. The authors believe that it is especially important to introduce aesthetic and functional prognosis into orthodontic practice in order to minimize aesthetic and psychological problems in patients.
Clinical characteristics of athlete’s foot and its combinations with dermatophytosis of other localizations
Background: Athlete’s foot (AF) is the most common fungal infection of the skin, characterized by various clinical manifestations. Dermatophytosis of other localizations can result from autoinoculation from a source on the feet. The relationship between the clinical forms of mycotic lesions of the feet and the spread of the pathological process to other areas of the skin has not been sufficiently studied. Objective: Evaluation of the clinical forms of AF and their combinations with dermatophytosis in other locations. Materials and methods: The study included 125 patients with AF aged 20–86 years, including 57 (45.6%) men and 68 (54.4%) women. The patients were divided into 2 groups: group 1 – 40 people with a combination of dermatophytosis of the feet and dermatophytosis of the skin beyond them, group 2 – 85 patients with dermatophytosis of the feet without changes in other areas of the skin. All patients underwent registration of anamnesis data and a clinical examination with photo fixation after signing informed consent. In order to detect fungal mycelium, direct microscopic examination with 10% NaOH was performed from the lesions, including the nail plates when they changed. The clinical form of AF was assessed based on visual examination. Results: There were no significant differences in the distribution of patients in the two groups by age (p=0.95) and gender (p=0.955). Among patients in Group 1, the squamous form of AF was detected in 60% of cases (p=0.007), the disease duration was over 5 years in 85% (p=0.048), and onychomycosis of the toes was found in 95% (p<0.05). The most common foci of dermatophytosis were localized in the groin area (37.5%), on the smooth skin of the shins (20%) and trunk (20%). Conclusion: The spread of fungal infection beyond the feet occurs in patients with the most clinically unexpressed (squamous) form of the disease, does not depend on the patient’s gender and is combined with damage to the nail plates, with frequent involvement of the skin of the inguinal folds.
Retrospective cohort study of the association between previous syphilis and the risk of developing acute cerebrovascular accident
Background: The possibility of vascular damage in syphilis has been considered by scientists for a long time. Currently, the list of mechanisms of influence of Treponema pallidum both on the endothelium in general and on the blood-brain barrier in particular has been significantly expanded. However, the question of the consequences of syphilis for the human body remains debatable even in the case of fully administered specific therapy. Objective: Retrospective cohort study to confirm the relationship between syphilis and the risk of developing acute cerebrovascular accident. Materials and methods: A retrospective cohort study of the medical records of 2022 patients hospitalized with suspected acute cerebrovascular accident (ACVA) in 2017–2018 was conducted. The study groups were divided into the following: the main group (n=36) – patients with a history of confirmed syphilis, the comparison group (n=35) – patients without syphilis. Clinical, instrumental (MSCT, MRI) and laboratory research methods (ELISA, CP) were used. Results: In the main group, ACVA developed 19 years earlier (mean age 51.8±10.5 years). The incidence of ischemic stroke was comparable (66% versus 68.5%), but patients with syphilis more often had combined arterial lesions (12.5% versus 0%) and papilledema (65.3% versus 22%). Conclusion: Previous syphilis can increase the risk of early development of stroke and contribute to more severe neurological complications, which requires the development of secondary prevention measures.
Justification and selection of a hepatoprotective agent for the complex therapy of patients with psoriasis
Background: Psoriasis is a common chronic multifactorial, immune-mediated inflammatory skin disease, often associated with a high risk of developing comorbid cardiovascular diseases, metabolic syndrome, as well as liver pathology, including iatrogenic, ari-sing in the process of systemic therapy, which is reflected in a brief review of domestic and foreign publications. Objective: Evaluation of the nature and severity of systemic inflammation indicators and the profile of changes in the blood serum lipid spectrum in patients with severe psoriasis, justification of the choice of a hepatoprotective agent with a pathogenetically justified complex effect. Materials and methods: A clinical and laboratory examination of patients with severe psoriasis (PASI index over 20 points) with an assessment of hemogram indicators, biochemical hepatogram, including peripheral blood lipidogram, group and subgroup data analysis using the Statistica 10 program was conducted. Results: In patients with severe clinical manifestations of psoriasis (in the absence of joint lesions), a pronounced proinflammatory reaction of the peripheral blood with an increase in the neutrophil/lymphocyte ratio in combination with a high serum CRP-ultra level was established. It was shown that the presence of immune-mediated inflammation in this cohort of patients with psoriasis was combined with high atherogenic lipidogram indices and reduced serum phospholipid levels, which are “predictors” of the formation of comorbid cardiovascular and liver pathology. Conclusion: The results of the study confirm the need to include a hepatoprotector in the complex therapy of patients with psoriasis and justify the choice of a drug containing essential phospholipids and glycyrrhizic acid, which is determined by the pharmacological properties of this drug providing both a “replacement”, hepatoprotective, and anti-inflammatory effect in psoriasis and comorbid conditions.
Possibilities of presarcopenia and sarcopenia prevention in the face using synchronized radiofrequency technology and High-Intensity Facial Electrical Stimulation (HIFES)
Background: Sarcopenia, characterized by a progressive loss of skeletal muscle mass and strength, is a significant problem for the elderly, leading to a decrease in the quality of life and increased risk of falls and disability (EWGSOP, 2018). Despite the existing diagnostic criteria and assessment methods, gaps remain in the understanding of genetic and epigenetic factors that contribute to the development of preservation, which emphasizes the need for further research in this area. Objective: to study the genetic and phenotypic predisposition to preservation and early sarcopenia in women aged 35–55 years, including with signs of undifferentiated connective tissue dysplasia (NDST) and evaluate the capabilities of the combined methodology of synchronized monopolar RF-lifting and electric field of high voltage (HIFES) as a prevention and the prevention and quality Correction of age -related changes at different types of aging. Materials and methods: 36 women aged 35–55 years are included in pilot research. All patients were performed: an assessment of the composition of the body using bioimpedansometry (phase angle, active cell mass), cystic dynamometry, spirometry (Fjel, OFV1), molecular genetic tests (RS1800012_COL1A1, RS1800255_COL3A1, RS7787362_LN, RS1799750_MMP1) and used SARC-F1 and Face-Q questionnaires, a questionnaire to identify signs of NDST. Results: Among 36 women aged 35–55 years with signs of violations in the synthesis and decay of collagen and elastin, satisfaction after the Emface procedures was clinically significant in patients with muscle type of aging. Dynamometry revealed a statistically significant decrease in the compression force of a brush in a group with signs of NDST (p=0,001). Genetic analysis showed that 89% of patients with signs of NDST had the polymorphism of the RS1800255_COL3A1 gene, which is much higher than in the control group (р<0,001). The SARC-F1 questionnaire demonstrated low sensitivity, emphasizing the need to create new screening profiles. Conclusions: As a result of the study, an assessment of the development of preservation and sarcopenia in patients with and without and without. The discovered associations between the signs and the diagnostic capabilities of evaluating the risk of sarcopenia (bioimedance, dynamometry, spirituality and screening questionnaire to detect a predisposition to undifferentiated connective tissue dysplasia (NDST)) emphasize the expediency of the individualized approach, which includes a molecular genetic Diagnostics. The combined EMFACE methodology is potentially applicable as part of preventive programs, however, to confirm its contribution to the prevention of sarcrophy development, controlled studies are required for a long period of observation.
Study of the effect of equine type I collagen preparation on the process of collagenesis in an experimental model using gene expression measurements and histological assessment of tissues
Objective: Evaluation of the effect of equine type I collagen on the collagenesis process in a mouse model by measuring gene expression in mouse skin (genes: COL1, COL3, MMP1, MMP3, ELN, VCAN, IL-6, TNFα, TGFβ) and performing histological examination of tissues. Materials and methods: The study used female BALB/C mice aged 6–8 weeks. The animals were kept under standard vivarium conditions at controlled temperature (22 ± 2 °C), humidity (50 ± 10%) and 12/12-hour light regime with access to water and food ad libitum. Experimental animals were shaved with two skin areas of ~3 cm² on the dorsal surface using a trimmer (day 0). On the next day (day 1), 100 μl of sterile saline (0.9% NaCl, control) were injected intradermally into one area, and 100 μl of equine collagen type I solution diluted in sterile saline according to the manufacturer’s instructions into the other ones. On day 1 of the experiment (24 hours after the first injection of the drug), one of the animals was sacrificed and skin areas in the injection areas were excised. Gene expression was measured using real-time polymerase chain reaction with reverse transcription (RT-rtPCR). Histological analysis was performed on the 21st, 35th, and 53rd days. Results: On day 1 of the experiment (24 hours after the first injection of equine collagen type I), a statistically significant increase in the expression of the COL1 and COL3 genes encoding collagen types I and III, the main structural proteins of the dermis, was observed in the tissues. This clearly indicates the initiation of new collagen synthesis by fibroblasts. Additionally, a significant increase in the TGFβ expression was recorded, which is one of the key regulators of fibroblast activity and differentiation, which is also known as a powerful inducer of collagenesis. Histological data confirm these molecular observations: on the 21st day, a higher ratio of fibroblasts to the total number of dermal cells and a denser organization of collagen fibers were found in the experimental samples than in the control group. Considering that fibroblasts are the main producers of extracellular matrix components, inclu-ding collagen, their high density in the dermis serves as an indirect sign of activation of the synthetic function of the skin under the influence of the drug. A tendency towards an increase in the thickness of the dermis on the 35th day was also revealed in the experimental group, which may reflect the accumulation of a new matrix and structural reorganization of the tissue. At the same time, the structure of collagen fibers on the 35th and 53rd days remained compact and dense, which indicates stabilization of the remodeled matrix.
History of the development of foreign and domestic classifications of skin and venereal diseases
Background: Dermatovenereology is a relatively young specialty. As a science, it has existed since the 18th century, and became completely independent only in the second half of the 19th century. At the same time, dermatovenereology has its roots in the origins of medicine. In some nations, dermatovenereology has achieved the greatest development in comparison with other areas of medical science, since skin diseases were much more accessible to the visual and tactile sensations of doctors; there were even separate names for skin diseases. Objective: Evaluation of the foreign and domestic experience in the development and implementation of medical classifications, including in dermatovenereology. Materials and methods: Collection, analysis and synthesis of the material were carried out on the basis of previously approved international and domestic classifications of diseases and conditions, as well as clinical classifications of individual dermatovenereological diseases. Results: When looking retrospectively at the development of dermatovenereology, it is worth noting the influence of various natural history and medical disciplines on its formation. Important foundations of dermatovenereology were laid by such sciences as bacteriology, immunology, the doctrine of the constitution, the endocrine glands, the autonomic nervous system, etc. Each discovery in any of these fields still does not lose its relevance and is used by dermatovenerologists and cosmetologists to this day. The influence of bacteriology and immunology on the development of the classification of skin and venereal diseases is especially great. The material accumulated in this direction brings us closer to the moment when, instead of the existing imperfect classifications of dermatoses, it will be possible to create a single scientifically based etiological and pathogenetic nomenclature, which will significantly contribute to improving the diagnosis and treatment of the corresponding diseases.
Modern view of the problem of non-syndromic ichthyosis
Non-syndromic ichthyosis is a genetically determined disorder of keratinization, characterized by universal skin desquamation. The most common type is ichthyosis vulgaris, which is caused by autosomal semi-dominant mutations of filaggrin. Recessive X-linked ichthyosis is more common in boys and is caused by steroid sulfatase deficiency. Autosomal recessive congenital ichthyosis is genetically very heterogeneous. The most common cause is transglutaminase deficiency type 1. Keratinopathic ichthyoses, such as epidermolytic ichthyosis, are caused by mutations in keratin genes. They are evident at birth and often accompanied by blistering. Most of these types are inherited as autosomal dominant traits, but autosomal recessive forms can also occur. The characteristic clinical manifestations of non-syndromic ichthyoses, the heterogeneous clinical course and the imperfect correlation between phenotype and genotype make diagnosis difficult. At the same time, accurate molecular diagnostics are crucial for prognosis and the provision of appropriate genetic counseling. Most non-syndromic ichthyoses have a significant impact on the quality of life of patients and, in severe cases, can lead to significant disability and loss of ability to work. A better understanding of the molecular mechanisms underlying these diseases is necessary to develop innovative therapeutic solutions focused on pathogenesis and taking into account individual patient characteristics.
Modern effective means of topical therapy and skin care for patients with psoriasis
The problem of topical therapy for patients with chronic dermatoses remains relevant in modern dermatology, despite a significant number of research works. The creation of new combined skin care products for patients with psoriasis allows potentiating the effect of most drugs in the absence of side effects in the form of allergic reactions, drug dependence and effects on other organs. Psoriasis in approximately 80% of patients manifests itself in a mild or moderate degree and is initially treated with local (topical) therapy. In the spectrum of topical therapy, glucocorticosteroids, betamethasone/calcipotriol, vitamin D3 analogues are effective. The domestic company Pharmtec has created a series of care products: Depsoriol® cream and lotion for patients suffering from vulgar psoriasis, including lesions of the scalp. In the study, when using this drug simultaneously with leading topical therapy products, or with subsequent care, a more rapid achievement of the clinical effect, positive dynamics of the psoriasis area and severity index (PASI) and the dermatological quality of life index (DQLI), compared with other skin care products, and the absence of side effects were noted.
Current concepts of hidradenitis suppurativa. Experience with interleukin-17 inhibitor in a patient with severe hidradenitis suppurativa
Hidradenitis suppurativa (HS) is a chronic inflammatory dermatosis characterized by a recurrent, debilitating course and significantly reducing the quality of life of patients. The disease can lead to irreversible changes in the skin in the form of scars and fistulas. The incidence worldwide is up to 1% of the population, most often affects young people aged 18 to 50 years, although cases have also been registered in adolescence. Women are more often affected, the ratio to men is 3:1. The disease is of an immune-mediated inflammatory nature and is often associated with multiple comorbid pathologies: metabolic syndrome, obesity, diabetes mellitus, arterial hypertension, dyslipidemia, inflammatory bowel disease and joint damage. The genetic factor is currently assigned a leading role in the development of pathology; it has been identified that mutations in 4 genes (PSENEN, NCSTN, TMED10 and WNT10A) can lead to disruption of keratinization processes and be the cause of disruption of cytokine regulation and imbalance in the T-helper cell axis of the 17th type, similar to that in patients with psoriasis. The use of topical and systemic antibacterial drugs, antiseptics, retinoids and steroids often does not lead to stable improvement and remission in patients with severe hidradenitis suppurativa. Genetically engineered biological therapy is a promising direction for the treatment of moderate to severe hidradenitis. Inhibition of the cytokine IL-17 shows good results in this group of patients. This article presents the experience and results of 12-week treatment of a patient with severe hidradenitis suppurativa (stage 3 according to Hurley) with the IL-17A inhibitor secukinumab.
A case report of partial erythroderma during Hodgkin lymphoma therapy
Background: Due to its high metabolic rate, the skin is one of the main target organs for the development of chemotherapy-associated side effects. The effects range from the most common but nonspecific rashes to rare but more typical skin lesions. The physician’s task is to recognize patterns of manifestations that reflect the skin’s response to drug therapy, identify a likely trigger, and determine whether the reaction is dose-dependent toxicity [1]. Skin toxicity is a common problem in the treatment of hemoblastoses. Dermatological side effects cause physical and psychological discomfort and can also serve as a reason for abandoning therapy for the underlying hematological disease [2]. With the expansion of the range of therapeutic options for antitumor therapy, dermatological side effects are also becoming more diverse and complex for the physician [2]. Description of the clinical case: The article presents a clinical observation of a patient with developed partial erythroderma of presumably psoriatic genesis against the background of combination therapy for Hodgkin’s lymphoma. Conclusion: The presented case allows to increase physicians’ awareness of the clinical diversity of manifestations of skin toxicity against the background of antitumor therapy for hemoblastoses.
Clinical case: comparative results of using high-intensity focused electromagnetic stimulation with monopolar radio-wave lifting as monotherapy and in a combined protocol with botulinum toxin
Facial aging is a complex process that results from changes in several layers: skin, subcutaneous fat, superficial muscular aponeurotic system (SMAS), muscles and bone. Facial muscles tend to lose their tone at rest, which leads to a change in the position of tissues. This article presents clinical cases of successful use of a new device that combines the technologies of high-intensity focused electromagnetic stimulation (HIFES) and monopolar radio-wave lifting (RF) to improve skin elasticity and muscle tone, used as monotherapy (HIFES + RF) and as a complex effect (HIFES + RF and botulinum therapy); their safety, effectiveness and patient satisfaction are assessed. The protocol in the form of a complex effect of HIFES, monopolar radio-wave lifting and botulinum toxin type A shows the highest results in comparison with a monoprocedure, and also allows for personalized cosmetology correction of involutional atrophy of the skin of the lower third of the face and neck.
Psoriasis of special localizations. Experience with the use of the interleukin-17A inhibitor netakimab for the treatment of psoriasis of special localizations
Psoriasis is a chronic immune-mediated inflammatory disease characterized by widespread characteristic lesions of the skin, nail plates and the development of comorbid pathologies (psoriatic arthritis, metabolic syndrome, cardiovascular diseases, etc.), which affects up to 11% of the world’s population. Psoriasis of the scalp, nails, palmoplantar area and genitals, which is often considered “difficult to treat”, is associated with a significant decrease in health-related quality of life (HRQoL) and may be a predictor for the development of psoriatic arthritis. Involvement of specific areas in patients with psoriasis may occur in up to 80–90% of cases at least once during life. The prevalence of involvement of these areas on average is: scalp – 45–56%, genitals – 30–40%, nail psoriasis – in 23–27% of cases, rashes on the face – 49%, palms and soles – 12–16% and intertriginous areas – 21–30%. The quality of life of patients with psoriasis of «difficult localizations» can be disproportionately affected, for example, due to the presence of lesions in visible areas, the patient’s self-esteem may be reduced, or involvement of the palms may lead to limitations in daily activities. Patients most often report feelings of shame, embarrassment and stigmatization. The goal of psoriasis treatment is supposed to be a reduction in the affected body surface area, stable remission and maintenance of «clear skin», which leads to a significant improvement in the patients’ health-related quality of life and their ability to work. Guidelines for the treatment of psoriasis in special localizations recommend considering systemic therapy, especially if topical therapy has proven ineffective. This article presents the results of successful treatment of patients with psoriasis of special localizations with the biologic drug IL-17A inhibitor netakimab.